Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA

Genome Research

Volumn 22, Issue 6, 2012, Pages 1120-1127

  Statham, Aaron L ^a   Robinson, Mark D ^a,b,c   Song, Jenny Z ^a   Coolen, Marcel W ^a,d   Stirzaker, Clare ^a,e   Clark, Susan J ^a,e  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; DNA; FORMALDEHYDE; HISTONE; POLYCOMB GROUP PROTEIN;

ALLELE; ARTICLE; CANCER CELL; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE LOCUS; GENE SILENCING; HIGH THROUGHPUT SEQUENCING; HISTONE MODIFICATION; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER;

ALLELES; CELL LINE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EPITHELIAL CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTONES; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; REFERENCE VALUES; SULFITES;

EID: 84861916932     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.132076.111     Document Type: Article

References (31)

1. Angrisano T, Sacchetti S, Natale F, Cerrato A, Pero R, Keller S, Peluso S, Perillo B, Avvedimento VE, Fusco A, et al. 2011. Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells. Nucleic Acids Res 39: 1993-2006.
2. Cedar H, Bergman Y. 2009. Linking DNA methylation and histone modification: Patterns and paradigms. Nat Rev Genet 10: 295-304.
3. Clark SJ, Harrison J, Paul CL, Frommer M. 1994. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22: 2990-2997. (Pubitemid 24260626)
4. Clark SJ, Statham A, Stirzaker C, Molloy PL, Frommer M. 2006. DNA methylation: Bisulphite modification and analysis. Nat Protoc 1: 2353-2364.
5. Collas P. 2010. The current state of chromatin immunoprecipitation. Mol Biotechnol 45: 87-100.
6. Coolen MW, Statham AL, Gardiner-Garden M, Clark SJ. 2007. Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: Critical evaluation and improvements. Nucleic Acids Res 35: e119. doi:10.1093/nar/gkm662.
7. Coolen MW, Stirzaker C, Song JZ, Statham AL, Kassir Z, Moreno CS, Young AN, Varma V, Speed TP, Cowley M, et al. 2010. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat Cell Biol 12: 235-246.
8. Egelhofer TA, Minoda A, Klugman S, Lee K, Kolasinska-Zwierz P, Alekseyenko AA, Cheung MS, Day DS, Gadel S, Gorchakov AA, et al. 2011. An assessment of histone-modification antibody quality. Nat Struct Mol Biol 18: 91-93.
9. Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, Zhang X, Lin JC, Liang G, Jones PA, Tanay A. 2008. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci 105: 12979-12984.
10. Gu H, Bock C, Mikkelsen TS, Jager N, Smith ZD, Tomazou E, Gnirke A, Lander ES, Meissner A. 2010. Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat Methods 7: 133-136.
11. Hahn MA, Hahn T, Lee DH, Esworthy RS, Kim BW, Riggs AD, Chu FF, Pfeifer GP. 2008. Methylation of Polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res 68: 10280-10289.
12. Hawkins RD, Hon GC, Lee LK, Ngo Q, Lister R, Pelizzola M, Edsall LE, Kuan S, Luu Y, Klugman S, et al. 2010. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6: 479-491.
13. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, et al. 2008. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 40: 741-750. (Pubitemid 351748874)
14. LairdPW. 2010. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 3: 191-203.
15. Laurent L, Wong E, Li G, Huynh T, Tsirigos A, Ong CT, Low HM, Kin Sung KW, Rigoutsos I, Loring J, et al. 2010. Dynamic changes in the human methylome during differentiation. Genome Res 20: 320-331.
16. Li Y, Tollefsbol TO. 2011. Combined chromatin immunoprecipitation and bisulfite methylation sequencing analysis. Methods Mol Biol 791: 239-251.
17. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
18. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, et al. 2009. Human DNA methylomes at base resolutionshowwidespread epigenomic differences. Nature 462: 315-322.
19. Matarazzo MR, Lembo F, Angrisano T, Ballestar E, Ferraro M, Pero R, De Bonis ML, Bruni CB, Esteller M, D'Esposito M et al. 2004. In vivo analysis of DNA methylation patterns recognized by specific proteins: Coupling CHIP and bisulfite analysis. BioTechniques 37: 666-673. (Pubitemid 39391183)
20. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, et al. 2008. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454: 766-770.
21. Mikkelsen TS, KuM, Jaffe DB, Issac B, Lieberman E, GiannoukosG, Alvarez P, Brockman W, Kim TK, Koche RP, et al. 2007. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560. (Pubitemid 47206934)
22. Mohn F, Weber M, Rebhan M, Roloff TC, Richter J, Stadler MB, Bibel M, Schubeler D. 2008. Lineage-specific Polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell 30: 755-766.
23. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, et al. 2007. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39: 237-242.
24. Pellegrini M, Ferrari R. 2012. Epigenetic Analysis: ChIP-chip and ChIP-seq. Methods Mol Biol 802: 377-387.
25. Rand KN, Ho T, Qu W, Mitchell SM, White R, Clark SJ, Molloy PL. 2005. Headloop suppression PCR and its application to selective amplification of methylated DNA sequences. Nucleic Acids Res 33: e127. doi: 10.1093/nar/gni120.
26. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE, et al. 2007. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39: 232-236. (Pubitemid 46184355)
27. Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ. 2002. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene 21: 1048-1061. (Pubitemid 34174517)
28. Statham AL, Strbenac D, Coolen MW, Stirzaker C, Clark SJ, Robinson MD. 2010. Repitools: An R package for the analysis of enrichment-based epigenomic data. Bioinformatics 26: 1662-1663.
29. Suzuki MM, Bird A. 2008. DNA methylation landscapes: Provocative insights from epigenomics. Nat Rev Genet 9: 465-476. (Pubitemid 351693975)
30. Takeshima H, Yamashita S, Shimazu T, Niwa T, Ushijima T. 2009. The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands. Genome Res 19: 1974-1982.
31. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I, et al. 2007. Epigenetic stem cell signature in cancer. Nat Genet 39: 157-158. (Pubitemid 46184343)